Pfizer suspends sale of 4 antibiotics in India

Pfizer suspends sale and distribution of its life-saving antibiotics in India due to manufacturing process deviation

American pharmaceutical giant Pfizer has temporarily suspended the sale and distribution of its antibiotics, Magnex, Magnex Forte, Zosyn, and Magnamycin, that are used as life-saving injections, with immediate effect.

In a letter dated May 16, 2023, Pfizer issued a alert asking stockists, distributors, and hospitals, to seize use and distribution of the injections, citing a “deviation in the manufacturing process.”

Comments

This is a Premium Article, available exclusively to our subscribers.

Read 500+ such News or articles every month by subscribing today!
Monthly

Free

Limited Access

Limited View

Free weekly E-Paper

Subscribe Now
Monthly

$10

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Annual

$50

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Start the conversation

Become a member of New India Abroad to start commenting.

Sign Up Now

Already have an account? Login